Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Interventional Study of Intranasal Zavegepant for the Acute Treatment of Migraine

NCT07861412 is registered in ClinicalTrials.gov with American Center for Psychiatry and Neurology as lead sponsor.

NCT NCT07861412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07861412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Interventional Study of Intranasal Zavegepant for the Acute Treatment of Migraine
Lead sponsor
American Center for Psychiatry and Neurology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
March 30, 2028
Enrollment
250 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

migraine